Annenberg Center for Health Sciences
Addressing Neurodevelopment, Qualify of Life and Emerging Therapies in Dravet Syndrome Patients
The combined developmental and epileptic encephalopathy of Dravet syndrome provides significant diagnostic and treatment challenges. This activity focuses on key characteristics and clinical presentations of Dravet syndrome with the aim of early identification of persons with the syndrome, timely initiation and appropriate use of approved medications, and the need for a multidisciplinary care plan, particularly as individuals transition into adulthood. Dr. Wirrell also provides an overview of investigational disease-modifying therapies.
Author
Annenberg Center for Health Sciences
Category
Podcast website
Latest episode
Apr 29, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Disease-Modifying Therapies 29.04.2026 13:24
Antisense oligonucleotide– zorevunersen Histamine antagonist– clemizole hydrochloride Serotonin agonist– bexicaserin Gene therapy– ETX101
Optimizing Standards of Care 29.04.2026 20:10
Seizure management–cannabidiol, fenfluramine, stiripentol; ketogenic diet Multidisciplinary care Dravet Syndrome Foundation Transition Guide Seizure action plan
Improving Diagnosis 29.04.2026 7:45
Key features and triggers Imaging DS mimics Genetic testing
Developmental and Epileptic Encephalopathy 29.04.2026 13:39
Description and course Comorbidities SCN1A gene mutation Disease burden
Similar podcasts
Listen to the Addressing Neurodevelopment, Qualify of Life and Emerging Therapies in Dravet Syndrome Patients podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
